CollPlant Biotechnologies Ltd. (CLGN) Social Stream
CollPlant Biotechnologies Ltd (CLGN) Price Targets From Analysts
Use the tables below to see what analysts covering CollPlant Biotechnologies Ltd think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 27, 2021
The Trend in the Analyst Price Target
Over the past 142 days, CLGN's average price target has gone down $0.
Over the past 29 weeks, CLGN's average upside potential has been 28.93%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CLGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CLGN as an investment opportunity.
- In the context of all US stocks, CollPlant Biotechnologies Ltd's number of analysts covering the stock is higher than 4.71% of them.
- CollPlant Biotechnologies Ltd's average analyst price target is greater than 165.56% of stocks in the micro market cap category.
- CLGN has a lower variance in analysts' estimates than 52.3% of Healthcare stocks.
- CollPlant Biotechnologies Ltd's upside potential (average analyst target price relative to current price) is greater than 138.42% of Medical Equipment stocks.
Is CLGN a Buy, Hold or Sell? See the POWR Ratings now!